UPL Limited reported a strong operational performance for Q4FY26, with adjusted EBITDA rising 13 percent year-on-year to ₹36.5 billion, broadly in line with market expectations. However, higher tax expenses impacted profitability, leading to a miss at the PAT level. For the full fiscal year FY26, the company posted an 18 percent increase in adjusted EBITDA to ₹95.9 billion, surpassing management’s revised growth guidance of 12–16 percent.
Despite the robust performance, UPL refrained from issuing FY27 guidance due to volatility in crude-linked raw material prices and uncertain demand trends arising from the ongoing Middle East conflict. Nevertheless, analysts expect nearly 11 percent EBITDA growth in FY27, supported by market share gains and inventory-related benefits. The company continues to maintain a positive long-term outlook, with a revised June 2027 sum-of-the-parts (SOTP)-based target price of ₹890, compared to the earlier ₹850.
Strong Revenue Growth Across Key Business Platforms
UPL reported consolidated Q4FY26 revenues of ₹183.4 billion, up 18 percent year-on-year and ahead of estimates of ₹168.5 billion. The growth was primarily driven by strong performances across three of its four business platforms. The company’s core agrochemical business, UPL Corp, recorded a 20 percent increase in revenues to ₹145.3 billion. Growth was supported by:
*Ten percent volume growth
*Four percent pricing improvement
*Seven percent foreign exchange tailwinds across geographies
Meanwhile, the Seeds business delivered robust growth, with revenues rising 23 percent year-on-year to ₹22 billion. The segment benefited from similar volume growth, pricing gains, and favorable currency movements. Superform revenues increased ten percent to ₹22.7 billion, driven mainly by higher volumes and modest pricing gains. However, the UPL SAS segment witnessed a 10 percent decline in revenues to ₹6.1 billion due to seasonally weak demand and product discontinuation.
Margins Under Pressure Despite EBITDA Improvement
Although adjusted EBITDA increased to ₹36.5 billion, EBITDA margins declined by 92 basis points year-on-year to 19.9 percent. Consolidated profit after tax (PAT) rose 18 percent year-on-year to ₹10.6 billion, translating into earnings per share (EPS) of ₹12.6. However, PAT remained nearly 19 percent below estimates due to higher-than-expected tax expenses during the quarter.
Balance Sheet Strengthening Nears Completion
UPL continued to strengthen its balance sheet during FY26. Net debt declined by approximately $400 million year-on-year to US$1.6 billion by the end of FY26. Additionally, net debt-to-EBITDA improved significantly to 1.5x from 2x in FY25, reflecting disciplined financial management and stronger cash flows. Working capital remained largely stable at 57 days compared to 53 days in FY25.
With the balance sheet repair phase nearing completion, management indicated that capital expenditure could increase to US$300–350 million in FY27. The company also plans to increase investments in the Superform business for backward integration while expanding focus toward non-agrochemical growth opportunities.
Growth Outlook Remains Positive Amid Market Volatility
Although management withheld formal FY27 guidance due to uncertainty in crude-linked raw material costs and global demand conditions, the company remains optimistic about future growth prospects. Analysts believe UPL could continue to gain market share while benefiting from inventory normalization trends, which may support double-digit EBITDA growth in FY27. At the same time, the company’s improved balance sheet provides greater flexibility to pursue strategic investments and long-term expansion initiatives.
Speaking to the media, Mike Frank, Chief Executive Officer, UPL Corp commented thatlast year they grew their topline 18% in North America and 11% in Europe. This has also been enabled due to new products launched through innovation. Responding to a question from Chemical Industry Digest, he said “Last year we generated more than 160 million in our international crop protection business from new product launches. We launched over 300 products. One of our products is based on nutrient use efficiency technology, which helps farmers increase yields and enhances the application of fertilisers in farmers fileds. Considering the cost of fertilisers, this is immediately important now”.
They have also introduced insecticides that avoids insect resistance from single mode of action, which gives a lot of durability to control insects. So such new product introduction are a key part of their growth strategy. One of the main reasons that they had strong and industry leadership volume growth. They expect the momentum to continue into the next year too.
Talking about specialty chemicals, he informed Chemical Industry Digest that their chemicals and technologies are mainly used beyond the agrochemicals sector, which is what distinguishes their Supraform business. Their chemicals find use in pharma, consumer health as well as the consumer goods industry.
UPL sells crop protection products and technologies in over 140 countries and they informed that they have grown in energy geography they are in. In terms of investment they are planning US$225 to 250 million organic capex split between 60% tangible capex and 40% intangible capex. Their tangible capex will also be used for the backward integration for agrochemicals and also in new product areas in specialty areas. As for inorganic growth through acquisitions they keep evaluating opportunities and will not be rushing into any unless it offers merit and value.
Restructuring Concerns Continue to Weigh on Valuation
Despite the operational turnaround achieved over the past two years, investor sentiment remains cautious following the restructuring and business realignment plans announced in February 2026. The proposed restructuring has triggered a sharp de-rating in the stock over the past three months, as investors assess the long-term implications of the new organizational structure.
Market participants continue to focus on governance, execution risks, and the overall structure of the proposed reorganization. While concerns surrounding the current framework persist, analysts believe that a simpler and more transparent structure could significantly improve value creation for promoters, minority shareholders, and private equity investors alike. As per the press release, UPL’s strong operational execution and healthier balance sheet continue to support its long-term growth story, even as restructuring-related uncertainties remain a near-term overhang for the stock.
